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Eubacterium hallii is considered an important microbe in regard to intestinal metabolic
balance due to its ability to utilize glucose and the fermentation intermediates acetate
and lactate, to form butyrate and hydrogen. Recently, we observed that E. hallii is
capable of metabolizing glycerol to 3-hydroxypropionaldehyde (3-HPA, reuterin) with
reported antimicrobial properties. The key enzyme for glycerol to 3-HPA conversion is
the cobalamin-dependent glycerol/diol dehydratase PduCDE which also utilizes 1,2-
propanediol (1,2-PD) to form propionate. Therefore our primary goal was to investigate
glycerol to 3-HPA metabolism and 1,2-PD utilization by E. hallii along with its ability
to produce cobalamin. We also investigated the relative abundance of E. hallii in
stool of adults using 16S rRNA and pduCDE based gene screening to determine
the contribution of E. hallii to intestinal propionate formation. We found that E. hallii
utilizes glycerol to produce up to 9 mM 3-HPA but did not further metabolize 3-HPA
to 1,3-propanediol. Utilization of 1,2-PD in the presence and absence of glucose led
to the formation of propanal, propanol and propionate. E. hallii formed cobalamin
and was detected in stool of 74% of adults using 16S rRNA gene as marker gene
(n = 325). Relative abundance of the E. hallii 16S rRNA gene ranged from 0 to 0.59%
with a mean relative abundance of 0.044%. E. hallii PduCDE was detected in 63 to
81% of the metagenomes depending on which subunit was investigated beside other
taxons such as Ruminococcus obeum, R. gnavus, Flavonifractor plautii, Intestinimonas
butyriciproducens, and Veillonella spp. In conclusion, we identified E. hallii as a common
gut microbe with the ability to convert glycerol to 3-HPA, a step that requires the
production of cobalamin, and to utilize 1,2-PD to form propionate. Our results along
with its ability to use a broad range of substrates point at E. hallii as a key species within
the intestinal trophic chain with the potential to highly impact the metabolic balance as
well as the gut microbiota/host homeostasis by the formation of different short chain
fatty acids.
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INTRODUCTION
The mammalian intestine is densely populated by trillions of
bacteria belonging to an estimated 500–1,000 species that are
predominantly classified as Firmicutes and Bacteroidetes. Under
conditions of health, host and microbiota live in a mutualistic
relationship. The host supplies energy sources through ingestion
of food and secretion of metabolites from the epithelium, and the
key roles of the microbiota are the breakdown of nutrients such
as dietary and host derived glycans, the synthesis of hormones
and vitamins, and colonization resistance to pathogens (Chassard
and Lacroix, 2013; Lee and Hase, 2014). Short chain fatty acids
(SCFA), such as butyrate, acetate and propionate, formed during
microbial fermentation of dietary or host derived carbohydrates,
supply the host with energy but also mediate interactions with the
immune system (Louis et al., 2014).
Trophic interactions of microbes are required for glycan
degradation and fermentation. Complex carbohydrates derived
from diet or host (mucins) are degraded by fibrinolytic
or mucinolytic bacteria, further metabolism of the hexoses
and pentoses yields acetate, propionate, butyrate, formate,
succinate, and lactate (Chassard and Lacroix, 2013; Louis et al.,
2014). Propionate and butyrate are final products of bacterial
metabolism that can be taken up by the host. Succinate
can be further metabolized (for e.g., by Phascolarctobacterium
succinatutens) to form propionate. Formate is a substrate for
methanogenic archaea. Lactate can be used by many species. For
example Veillonella forms mainly acetate and propionate from
lactate. Members of the Lachnospiraceae such as Eubacterium
hallii and Anaerostipes spp. utilize acetate and lactate to produce
butyrate and also hydrogen (Duncan et al., 2004).
Due to its ability to utilize the intermediate lactate, E. hallii
is considered an important microbe in regard to intestinal
metabolic balance as lactate accumulation has been associated
with several intestinal diseases and malabsorption (Hove et al.,
1994; Duncan et al., 2004). However, the substrate utilization
spectrum is not limited to lactate and acetate, as E. hallii also
forms butyrate from glucose (Duncan et al., 2004), but does
not grow on or utilize more complex oligo- and polysaccharides
(Scott et al., 2014).
Recently, we observed that E. hallii is capable of metabolizing
glycerol to 3-hydroxypropionaldehyde (3-HPA) which in
aqueous solution exists in a multi-compound system called
reuterin (Engels et al., 2016). Reuterin has antimicrobial
activity against Gram-positive and Gram-negative bacteria,
fungi and yeast, probably by causing oxidative stress through
interaction with intracellular glutathione (Schaefer et al., 2010;
Vollenweider et al., 2010). Reuterin formation has previously
been reported for members of the genera Klebsiella, Enterobacter,
Citrobacter, Clostridium, and Lactobacillus (Vollenweider and
Lacroix, 2004). The key enzyme that catalyzes glycerol to
3-HPA conversion is the glycerol/diol dehydratase PduCDE
(Morita et al., 2008). A second substrate of this enzyme is
1,2-propanediol (1,2-PD) which can be further metabolized to
propanol or propionate thereby generating one ATP (Gänzle,
2015; Figure 1). Glycerol/diol dehydratases are cobalamin
(vitamin B12)-dependent enzymes. In Lactobacillus reuteri, a
cluster of 58 genes is involved in the biosynthesis of reuterin
and cobalamin (Morita et al., 2008). The pdu operon harbors
genes encoding for the glycerol/diol dehydratase as well as
enzymes which enable the formation of propionate if 1,2-PD is
present as substrate; genes required for cobalamin synthesis are
located within the cbi-cob-hem operon (Santos et al., 2008). We
observed that E. hallii harbored an almost complete pdu and cob
loci, however, in comparison to L. reuteri, gene synteny of the
pdu-cbi-cob-hem cluster was not preserved (Engels et al., 2016;
Supplementary Figure S1). E. hallii thus possesses the genomic
potential to metabolize glycerol and 1,2-PD, and to synthesize
cobalamin, however, phenotypic confirmation is missing.
Glycerol and 1,2-PD are readily available in the
gastrointestinal tract as they are derived from the metabolism
of triglycerides, or fucose and rhamnose, respectively. Latter are
building blocks of dietary (for e.g., human milk oligosaccharides)
or host derived glycans (mucin; Podolsky, 1985; Casas and
Dobrogosz, 2000). The ability of E. hallii to metabolize glycerol
and 1,2-PD could result in a competitive advantage by the
formation of the antimicrobial compound reuterin or the
production of propionate, respectively. Therefore, our primary
goal was to investigate the glycerol and 1,2-PD metabolism of
E. hallii. We also investigated the relative abundance of E. hallii
in adult stool samples derived from the human genome project
(HMP, Human Microbiome Project Consortium, 2012) using 16S
rRNA and pduCDE gene screening to determine the contribution
of E. hallii to intestinal propionate formation.
MATERIAL AND METHODS
Bacterial Strains and Culture Conditions
Stab cultures of E. hallii DSM 3353 and DSM 17630 were frozen
at −20◦C in YCFA agar (1.5% (w/v) agar, Supplementary Table
S1) and used as stock cultures. For each experiment, a fresh
agar stock was thawed; 1 ml of liquid YCFA medium was added
and thoroughly shaken before being transferred to 8 ml liquid
YCFA medium. After incubation at 37◦C for 72 h, the culture
was transferred at least once to fresh YCFA broth before the
experiment. The YCFA medium was prepared as described by
Duncan et al. (2004) with slight modifications and contained
approximately 33 mM acetate (mYCFA, Supplementary Table
S1). All components except L-cysteine were solubilized in
deionized water, pH was adjusted to pH 7.6 with NaOH.
After boiling and a color change from blue to pink, L-cysteine
(0.01%, w/v) was added and tubes were autoclaved. Unless
otherwise stated, mYCFA containing 180 mM glucose was used
to routinously cultivate E. halli. Stock cultures of L. reuteri DSM
20016, L. rossiae DSM 15814 and L. delbrueckii subsp. lactis DSM
20355 were maintained at −80◦C in 30% glycerol. Lactobacilli
were routinously grown in MRS at 37◦C for 24 h.
Growth in the Presence of Different
Substrates
Growth kinetics were assessed in mYCFA medium supplied with
glucose, glycerol, lactate or 1,2-PD as summarized in Table 1.
Hungate tubes containing 9 ml mYCFA were inoculated with
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FIGURE 1 | Glycerol and 1,2-propanediol metabolic pathways.
0.5 ml of overnight cultures of E. hallii strains DSM 3353 or
DSM 17630. Samples were taken after 0, 3, 6, 9, 12, and 24 h
of incubation for substrate and metabolite analysis. Bacterial
growth was evaluated by measuring the optical density at 600 nm
(OD600). Growth in the presence of glucose was investigated in
six independent replicates, all other substrates were tested in
independent triplicates.
Analysis of Glycerol and Its Conversion
Products, Glucose Consumption, and
SCFA Formation
Glucose consumption was measured using high performance
liquid chromatography (Merck-Hitachi, Darmstadt, Germany)
equipped with an Aminex HPX-87H column (300 mm× 7.8 mm;
BioRad) and a refractive index detector (HPLC-RI). Samples were
centrifuged at 13 000 g for 5 min at 4◦C. Supernatants (40 µL
TABLE 1 | Substrates (carbon sources) added to mYCFA medium.
Substrate Abbreviation Amount (mM)
Glucose mYCFA_glc 70
Glycerol mYCFA_gly 120
Glucose+glycerol mYCFA_glc_gly 70 + 120
Lactate mYCFA_lac 40
Lactate+glycerol mYCFA_lac_gly 40 + 120
1,2-PD mYCFA_pd 80
1,2-PD+glucose mYCFA_pd_glc 70 + 80
All media contained approximately 33 mM of acetate.
injection volume) were eluted with 10 mM H2SO4 at a flow rate
of 0.6 ml min−1 at 40◦C. Glucose was quantified using external
standards.
Glycerol, 1,2-PD, 1,3-propanediol (1,3-PD), 3-HPA,
3-hydroxypropionate, propanal, and propanol were quantified
with ion chromatography with pulsed amperometric detection
(IC-PAD) on a Thermo Scientific ICS-5000+ system equipped
with a quaternary gradient pump, a thermo autosampler, and
an electrochemical detector with a cell containing an Ag/AgCl
reference electrode and a disposable thin-film platinum working
electrode tempered at 25◦C. Analytes were separated on a
Thermo Scientific IonPac ICE-AS1 4 × 250 mm ion-exclusion
column with guard column operated at 30◦C using isocratic
conditions (0.1 M methanesulfonic acid; 0.2 mL min−1) for
36 min. The injection volume was 10 µL. Electrochemical data
was obtained using a triple potential waveform consisting of
regeneration/detection, oxidation and reduction potentials:
E1 = 0.3 V (t1 = 0.31 s), E2 = 1.25 V (t2 = 0.34 s, tint = 0.02 s),
E3 = −0.4 V (t3 = 0.39 s). Currents were measured and
integrated with respect to time (tint).
Short-chain fatty acids (SCFAs) acetate, propionate, butyrate,
formate, and lactate were quantified with IC with suppressed
conductivity detection on the previously described ICS-5000+
system using external standards. Analytes were separated on
a IonPac AS11-HC 4 × 250 mm column with guard column
operated at 30◦C using the following gradient conditions at 1.5 ml
min−1 using an eluent generator: 1.5 mM KOH, 0–6 min; 1.5–
35 mM KOH, 6–21 min; 35–60 mM KOH, 21–26 min; 60 mM
KOH, 26–27 min; 60–1.5 mM KOH, 27–28 min followed by
appropriate re-equilibration. The injection volume was 10 µL.
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Cobalamin Production
Cobalamin formation was determined as described by Langa
et al. (2013) using the cobalamin auxotrophic L. delbrueckii
subsp. lactis DSM 20355 as reporter strain. Known cobalamin
producers L. reuteri DSM 20016 and L. rossiae DSM 15814
(Sriramulu et al., 2008; De Angelis et al., 2014) as well as vitamin
B12-deficient assay medium with added vitamin B12 served as
positive controls. Vitamin B12-deficient assay medium without
any cellular extract was used as negative control. Bacterial growth
was determined by measuring the optical density at 600 nm
after incubation at 37◦C for 24 h. Biological duplicates of the
experiment were performed.
Minimum Inhibitory Concentrations of
Reuterin toward the Two Strains of
E. hallii
Minimum inhibitory concentrations (MICs) of reuterin toward
E. hallii strains DSM 3353 and DSM 17630 were determined using
serial dilutions of a reuterin solution containing 186 mM 3-HPA
added to mYCFA. Hereby, L. reuteri DSM 20016 was cultured
in MRS medium at 37◦C before washed cells were suspended in
glycerol solutions; reuterin was isolated from resulting solutions
as described previously (Vollenweider et al., 2003). mYCFA
containing reuterin was inoculated with overnight cultures of
E. hallii strains at 5% (v/v). Bacterial growth was determined
by measuring the OD600 after incubation at 37◦C for 24 h.
A sigmoidal equation was used to fit the data (Sigma Plot version
12); the inflection point of the resulting curves represented the
MIC50 value quantified as 3-HPA which was defined as the lowest
concentration that reduced final OD600 to 50% compared to
controls without inhibition. The experiment was performed in
four independent replicates for each strain.
16S rRNA Gene Library Screening
The 325 stool 16S rRNA gene sequences datasets from
the HMP (Human Microbiome Project Consortium, 2012)
were downloaded from ftp://public-ftp.hmpdacc.org/HM16STR
(SRA: SRP002395). The datasets contain∼6 million bacterial 16S
rRNA sequences from the variable regions V1–3, V3–V5, and
V6–9. Sequences are on average 406 bases long. The smallest
dataset contained 250 sequences, the largest contained 140,179
sequences with an average number of 18,370 sequences per
dataset.
Screening was performed using 16S rRNA gene sequences
extracted from E. hallii DSM 17630 and DSM 3353. Version 123
of the Silva 16S rRNA database (Quast et al., 2013) served as
additional reference.
Eubacterium hallii DSM 17630 and DSM 3353 16S rRNA gene
reference sequences were aligned against the Silva database using
MALT’s dynamic programming semi-global alignment algorithm
(Huson, 2014) to generate a list of potential false positives.
Sequences in Silva that aligned at an identity larger than 95% and
did not originate from E. hallii were labeled false positives.
Data from the 325 samples were then aligned against the
E. hallii reference database using the dynamic programming.
Only alignments with a minimum identity of 97% were reported.
Sequences shorter than 200 bp were excluded from the analysis.
Sequences fulfilling these criteria were extracted and aligned
against the Silva database using the same setting as described
above. Only input sequences where at least 90% of alignments
could be assigned to the genus E. hallii were considered positive
hits.
Metagenome Screening
The 152 stool metagenomic sequencing datasets created in the
scope of the HMP were downloaded from ftp://public-ftp.hmpda
cc.org/Illumina/stool/. The datasets contained 16.6 billion paired
and unpaired Illumina sequenced reads. The smallest dataset
contained 3 million sequences. The largest dataset contained 305
million sequences. On average datasets contained 109 million
sequences.
Screening was performed using PduC, PduD, and PduE from
the E. hallii DSM 3353 and L. reuteri JCM 1112 (PduCDE_DB).
The RefSeq (Pruitt et al., 2007) protein (Version: August-10-
2015) database served as additional database.
Data from the 152 datasets were aligned against the
PduCDE_DB database using DIAMOND (Buchfink et al., 2015).
Sequences that were successfully aligned in the previous step were
extracted and realigned against the RefSeq database (Pruitt et al.,
2007) using DIAMOND. The bit score of alignments of paired
reads that mapped to the same reference sequence were boosted
by 30%. Reads with the best scoring alignment to PduC, PduD or
PduE of E. hallii or L. reuteri were included in analysis.
Ten datasets with in particular high (SRS017521, SRS011271,
SRS018427, SRS050422, SRS015431) or low abundance
(SRS048164, SRS013800, SRS019787, SRS016018, SRS016585)
of E. hallii underwent a deeper metagenomic analysis. The
full datasets were aligned against the RefSeq database using
DIAMOND. Alignment scores were boosted if mate pairs
aligned to the same reference. Results were then taxonomically
classified using MEGAN’s lowest common ancestor algorithm
in combination with the NCBI taxonomy (Huson et al., 2011).
Functional classification was performed by extracting the best
scoring alignment of each read and mapping it to the GI protein
names.
RESULTS
Growth, Substrate Utilization and
Metabolite Formation of E. hallii in the
Presence of Glucose, Lactate and
Glycerol
We used two E. hallii isolates that are currently available from
public culture collections which were both isolated from human
stool samples: the type strain E. hallii DSM 3353 and the E. hallii-
like isolate DSM 17630 (L2-7, Duncan et al., 2004). Both strains
were grown in mYCFA medium containing various combinations
of glucose, lactate, glycerol, and 1,2-PD (Table 1, Supplementary
Table S1).
Eubacterium hallii reached highest OD (>1.5) when grown
in the presence of glucose. E. hallii DSM 3353 and DSM
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FIGURE 2 | Growth (A), butyrate formation (B), glycerol utilization (C), and 3-HPA production (D) of Eubacterium hallii DSM 3353 in the presence of
glycerol (mYCFA_gly), glucose (mYCFA_glc), glucose and glycerol (mYCFA_glc_gly), lactate (mYCFA_lac), and lactate and glycerol (mYCFA_lac_gly).
17630 used 32.8 ± 9 and 21.3 ± 5.1 mM of glucose supplied
while producing equimolar amounts of butyrate (Supplementary
Table S2, Figures 2A,B and 3A,B). When glycerol was added
(mYCFA_glc_gly), growth of E. hallii was reduced and reached
a maximum OD600 of about 0.7; little amounts of butyrate
(<4 mM) were formed.
Eubacterium hallii DSM 3353 and DSM 17630 were also
grown in the presence of lactate (mYCFA_lac), and of both lactate
and glycerol (mYCFA_lac_gly). In mYCFA_lac, the lag phase
was extended and the final OD600 of E. hallii was lower than in
mYCFA_glc (Figures 2A and 3A). The molar amount of butyrate
produced was approximately half of the molar sum of lactate
and acetate utilized (Supplementary Table S3). All lactate was
utilized within 12 and 24 h of fermentation of E. hallii DSM 3353
and 17630, respectively, (Supplementary Table S3). The addition
of glycerol to mYCFA containing lactate (mYCFA_lac_gly) also
inhibited growth, lactate and acetate consumption (Figures 2A
and 3A, Supplementary Table S3).
When only glycerol was supplied instead of glucose
(mYCFA_gly), E. hallii DSM 3353 did not grow while the
OD600 of DSM 17630 increased by 0.35 units within 3 h of
incubation (Figures 2A and 3A). The amount of butyrate
produced was less than 3 mM for both strains and acetate was
not utilized (Figures 2B and 3B, Supplementary Table S3).
Glycerol was converted to 3-HPA in all samples containing
glycerol (Figures 2C,D and 3C,D), irrespective of any other
carbon sources present. Maximum 3-HPA concentrations
were obtained after 6 h of incubation corresponding to 7 and
9 mM for E. hallii DSM 3353 and DSM 17630, respectively.
Thereafter, the concentration of 3-HPA decreased steadily to
undetectable levels. 1,3-PD was either not detected or present
only at very low concentration of less than 1 mM throughout
the incubations (data not shown). The reference compound for
3-hydroxypropionate, the alternative end product for glycerol
metabolism (Figure 1; Gänzle, 2015) eluated as two peaks. As
after growth of E. hallii in the presence of glycerol, no peaks at
the rention times of the 3-hydroxypropionate standard appeared,
it was assumed that 3-hydroxypropionate was not formed.
Growth, Substrate Utilization and
Metabolite Formation of E. hallii in the
Presence of 1,2-PD
We also investigated the growth behavior of E. hallii in the
sole presence of 1,2-PD (mYCFA_pd), and in combination with
glucose (mYCFA_pd_glc). The presence of 1,2-PD impacted the
growth of the two E. hallii strains differently: Growth of E. hallii
DSM 3353 was similar in the presence and absence of 1,2-
PD while the final optical density of E. hallii DSM 17630 was
significantly reduced by the addition of 1,2-PD (Figures 4A and
5A). In mYCFA_pd_glc neither strain used glucose, and butyrate
was not produced (Figures 4B and 5B, Supplementary Table S2).
In mYCFA_pd, E. hallii DSM 3353 consumed all 1,2-PD
within 9 h of incubation (Figures 4C and 5C), resulting
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FIGURE 3 | Growth (A), butyrate formation (B), glycerol utilization (C), and 3-HPA production (D) of E. hallii DSM 17630 in the presence of glycerol
(mYCFA_gly), glucose (mYCFA_glc), glucose and glycerol (mYCFA_glc_gly), lactate (mYCFA_lac), and lactate and glycerol (mYCFA_lac_gly).
in the accumulation of propanal, propanol and propionate
(Figures 4 and 5D–F). The molar yield of propanal, propanol
and propionate added up to the molar amount of 1,2-PD used
(Figure 6). Slower 1,2-PD utilization was detected when glucose
was added (mYCFA_pd_glc) then without (mYCFA_pd). Hereby
propanal did not accumulate and significantly (p < 0.05) more
propanol was formed by E. hallii DSM 3353 (Figure 4). The
utilization of 1,2-PD and corresponding metabolite formation
was similar for E. hallii DSM 17630, however, the final amount of
propanol produced was not significantly different in the absence
or presence of glucose (Figure 5). E. hallii DSM 3353 and DSM
17630 produced about 20 and 10 mM of propionate, respectively,
after 24 h of incubation, independently of the presence of glucose
(Figures 4E and 5E).
Cobalamin Formation
The glycerol/diol dehydratase of L. reuteri is a cobalamin-
dependent enzyme. E. hallii DSM 3353 possesses most of
the genes necessary to form cobalamin (Engels et al., 2016;
Supplementary Figure S1). To investigate whether E. hallii is
able to synthesize cobalamin, a reporter strain assay employing
cobalamin-auxotrophic L. delbrueckii subsp. lactis DSM 20355
as indicator strain was conducted. L. delbrueckii subsp. lactis
grew after addition of cellular extracts of L. reuteri DSM 20016
and L. rossiae DSM 15814, which were used as positive controls.
Addition of cell extracts of both E. hallii strains also resulted in
growth of L. delbrueckii subsp. lactis (Supplementary Figure S2).
Thus, we could confirm here that both strains of E. hallii are able
to form cobalamin.
MIC50 Values of Reuterin toward E. hallii
To determine the MIC50 values of reuterin toward E. hallii,
both strains were grown in serial dilutions of reuterin in
YCFA medium. OD600 values measured after 24 h of growth at
37◦C were plotted against corresponding 3-HPA concentrations
(Supplementary Figures S3A,B). The inflection points of the
resulting curves were used to calculate MIC50 values. The
MIC50 values of reuterin were determined to be 3.7 ± 0.2 mM
(quantified as 3-HPA) for E. hallii DSM 3353 and also for E. hallii
DSM 17630. In correspondence with these MIC50 values, visible
growth of both strains was detectable in the presence of up to
7–8 mM 3-HPA (Supplementary Figures S3A,B).
Abundance of E. hallii in 16S rRNA Gene
Libraries and Metagenomes Derived
from the HMP
We screened a total of 325 16S rRNA gene libraries obtained
from the HMP for the occurrence and relative abundance of
Frontiers in Microbiology | www.frontiersin.org 6 May 2016 | Volume 7 | Article 713
fmicb-07-00713 May 17, 2016 Time: 17:2 # 7
Engels et al. Eubacterium hallii Contributes to Propionate Formation
FIGURE 4 | Growth (A), butyrate formation (B), 1,2-PD utilization (C), and propanal (D), propionate (E), and propanol (F) formation by E. hallii DSM
3353 in the presence of 1,2-PD (mYCFA_pd), glucose (mYCFA_glc), and glucose and 1,2-PD (mYCFA_pd_glc).
E. hallii. Sequences were aligned against the 16S rRNA gene of
E. hallii strains DSM 17630 and DSM 3353. Successfully aligned
sequences were then aligned against the Silva 16S rRNA database
to remove false positives. E. hallii was detected in stool of 74%
of the donors. Relative abundance ranged from 0 to 0.59% with
a mean relative abundance of 0.044%. Most individuals harbored
E. halliiwith relative abundance of less than 0.1% (Supplementary
Figure S4). We also used pduCDE as functional marker genes to
screen 152 metagenomes derived from stool of adults in the scope
of the HMP for the presence of E. hallii and L. reuteri. Sequences
were aligned against a database that contained PduC, PduD, and
PduE from E. halli and L. reuteri using DIAMOND. Successfully
aligned sequences were then aligned against the RefSeq protein
database in order to remove false positives. Depending on which
Pdu subunit was investigated, occurrence ranged from 63 to
81% for E. hallii (Table 2). In comparison, L. reuteri was low
abundant (0 to 2%) and PduC was only detected in 3 of 152
metagenomes.
Contribution of E. hallii to
Glycerol/1,2-PD Metabolism in the Gut
To further investigate to which extent E. hallii contributes to
glycerol/1,2-PD metabolism, we determined species contributing
glycerol/diol dehydratases using 10 metagenomes with high
(MG1-5) or low (MG6-10) abundance of E. hallii PduCDE
(Figure 7). In accordance to results obtained by screening for
the presence of PduCDE, contribution of E. hallii to the entire
glycerol/diol dehydratase pool was significantly higher (p< 0.05)
in MG1-5 (23.6 ± 10.6%) than in MG6-10 (2.3 ± 2.4%).
However, the relative abundance of all glycerol/diol dehydratases
in metagenomes with high (MG1-5) or low (MG6-10) abundance
of E. hallii was not significantly different (p > 0.05, log
−3.2 ± 0.4 versus −4.7 ± 0.9 relative abundance). In 9 out
of 10 metagenomes, E. hallii, Ruminococcus obeum, R. gnavus,
Ruminococcus sp. CAG:9, Flavonifractor prautii, Intestinimonas
butyriciproducens, and Veillonella spp. contributed more than
59% of all glycerol/diol dehydratases reads while in MG8, all
glycerol/diol dehydratases reads were assigned to Escherichia
coli (Figure 7). In general, a diverse pool of taxons potentially
contributing to glycerol and 1,2-PD metabolism and thus
propionate formation was identified.
Distribution of Propionic Acid Formation
Pathways
To investigate the contribution of the three major propionate
formation pathways in the human gastrointestinal tract, we
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FIGURE 5 | Growth (A), butyrate formation (B), 1,2-PD utilization (C), and propanal (D), propionate (E), and propanol (F) formation by E. hallii DSM
17630 in the presence of 1,2-PD (mYCFA_pd), glucose (mYCFA_glc), and glucose and 1,2-PD (mYCFA_pd_glc).
screened the previously mentioned 10 metagenomes for the
relative abundance of genes encoding methylmalonyl-CoA
decarboxylase Mmda, and lactoyl-CoA dehydratase Ldc,
which are key enzymes in succinate and acrylate pathways
(Reichardt et al., 2014), and compared to relative abundance
of PduCDE of the propanediol pathway. There was no
significant difference in relative abundance of key enzymes
of the three propionate pathways between metagenomes with
high or low abundance of E. hallii. Based on the relative
abundance of the key proteins of all three pathways, the
propanediol pathway contributed on average 31% to propionate
formation, the succinate pathway 64%, and the acrylate
pathway 5%.
DISCUSSION
Eubacterium hallii is a human gut microbe with a versatile
utilization of carbon sources as it can grow and form butyrate
using either glucose, or acetate and lactate as substrates.
Previous studies reported high abundance E. hallii in stool
of 84 adults from Italy with 5.8, 4.8, and 3.2% in young
adults, elderly and centenarians, respectively, determined using
HitChip (Biagi et al., 2010). In contrast the stool of 9 out of
10 adults presumably from the UK contained between 0.03 and
2% (mean 0.34%) as determined using FISH (Hold et al., 2003).
Relative abundance of E. hallii was 10–100 fold less in libraries
derived from HMP. Despite this discrepancy, we observed high
occurrence rates of E. hallii. Thus, E. hallii seems a regular
constituent of an adult-like gut microbiota.
In contrast to E. hallii, L. reuteri was only rarely detected in
adults. The ability to produce reuterin is conserved in strains of
L. reuteri isolated from human feces (Frese et al., 2011). However,
while being autochthonous in rodents and pigs forming biofilms
at the non-glandular stratified squamous epithelium lining the
upper gastrointestinal tract, L. reuteri occurs and persists only
in the human gastrointestinal tract of some individuals (Walter,
2008), a finding that, we confirmed in this study.
When grown in the presence of glucose, both E. hallii strains
produced equimolar amounts of butyrate. Molar amount of
butyrate produced in mYCFA_lac was approximately half of
the molar sum of lactate and acetate utilized; both findings
are well in agreement with previous reports (Duncan et al.,
2004). Glycerol is an abundant carbon source in the human
intestine resulting from incomplete digestion and absorption of
triglycerides, from luminal microbial fermentations, digestion
of luminal fats, sloughed mucus and desquamated epithelial
cells, as well as from intestinal clearing of endogenous plasma
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FIGURE 6 | 1,2-PD utilization and sum of propanal, propionate and propanol formed by E. hallii DSM 3353 (A) and DSM 17630 (B).
glycerol (Casas and Dobrogosz, 2000). According to Degnan
et al. (2014a,b) an estimated 11% of gut microbes possess
cobalamin-dependent glycerol/diol dehydratases and therefore
have the genomic potential to synthesize reuterin from glycerol.
The ecological role of reuterin formation remains to be
elucidated. In growing cultures of L. reuteri, 3-HPA gets
immediately reduced to 1,3-PD by a 1,3-PD dehydrogenase
when glycerol and glucose are present to enable co-factor
regeneration (Gänzle, 2015; Figure 1). Only during stationary
phase in the absence of glucose, 3-HPA gets released from
L. reuteri cells and accumulates in the medium (Vollenweider
and Lacroix, 2004). For E. hallii, the formation of reuterin
was observed whenever glycerol was present. The inconsistency
of molar amounts of glycerol used and of 3-HPA detected
during growth of E. hallii might be due to degradation of 3-
HPA or its binding to proteinaceous compounds present in
mYCFA and is well in agreement with previous observations
(Luthi-Peng et al., 2002; Engels et al., 2016). Concentrations
of about 7–8 mM (quantified as 3-HPA) completely inhibited
visual growth and metabolism of the producer strain which is
in agreement with growth inhibition observed in MIC50 assays.
MICs of E. hallii were approximately 10-fold less than those
observed for L. reuteri (30–50 mM) but were in the range
of those reported for other Eubacterium spp. (Cleusix et al.,
2007). In contrast to L. reuteri, metabolism of 3-HPA to 1,3-
PD was not observed under the test conditions suggesting
that E. hallii is not able to regenerate co-factors this way.
Therefore glycerol metabolism and reuterin formation does not
seem to enhance competitiveness of E. hallii in its ecological
niche.
The other possible substrate of glycerol/diol dehydratases
is 1,2-PD (Figure 1). 1,2-PD is derived from fermentation of
fucose and rhamnose which are transformed by the activity
of fucose/rhamnose isomerases, kinases and aldolases finally
yielding L-lactaldehyde which can be further reduced to 1,2-
PD by the activity of a propanediol oxidoreductase (Boronat
and Aguilar, 1981). E. hallii does not harbor genes related to
fucose and rhamnose utilization (genome ID: SAMN02415618).
However, several gut microbes are capable of forming 1,2-PD
(Saxena et al., 2010). Within the draft genome of E. hallii, we
could identify homologs of L. reuteri pduQ, pduP, and pduW
(Supplementary Figure S1) encoding enzymes which catalyze
the transformation of propanal to propanol and propionate.
There was, however, no homolog of L. reuteri pduL which
presumably encodes the enzyme that transforms propionyl-
CoA to propionyl phosphate. Nevertheless, as we observed the
formation of propionate, it can be assumed that another enzyme
is responsible for the phosphorylation. It can also be suggested
that the metabolism of 1,2-PD to propionate increases the
competitive advantage of E. hallii as this transformation generates
one additional ATP (Gänzle, 2015).
Eubacterium hallii formed similar amounts of propionate in
the presence or absence of glucose and did not utilize glucose
if 1,2-PD was present. In contrast, butyrate formation from
lactate only occurred when glucose was depleted (Duncan et al.,
2004). In vivo, both pathways can be expected to happen as
glucose is generally of low abundance in the colon. Due to
its versatile metabolic activity, E. hallii seems to be able to
impact the ratios of acetate and lactate and of butyrate and
propionate. Both butyrate and propionate are important in
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FIGURE 7 | Species contributing glycerol/diol dehydratases to the metagenomes of 10 individuals with high (MG1–MG5) and low (MG6–MG10)
abundance of E. hallii pduCDE; others, groups all species with low hits.
TABLE 2 | Occurrence and relative abundance of Eubacterium hallii and
Lactobacillus reuteri PduCDE subunits in stool metagenomes obtained
from HMP.
Best hits
Pdu subunit PduE PduD PduC
E. hallii
Occurrence 95/152 (63%) 103/152 (68%) 123/152 (81%)
Mean relative abundance 4 × 10−6 5 × 10−6 2 × 10−5
L. reuteri
Occurrence 0 0 3/152 (2%)
Mean relative abundance − − 2 × 10−8
gut microbiota/host homeostasis as they interact with the host
epithelium and impact the immune system. Butyrate is a main
energy source of colonocytes, it impacts cell proliferation and
differentiation, and lowers the risk of colitis and colorectal cancer
(Wong et al., 2006; Plöger et al., 2012). Propionate acts as
a precursor for gluconeogenesis in the liver and also impacts
cell differentiation with potential health promoting impact on
intestinal inflammation, and cancer development (Reichardt
et al., 2014).
In the intestine, acrylate, propanediol and succinate pathways
lead to the production of propionate (Reichardt et al., 2014).
The latter has been considered to contribute the most to
propionate formation due to the widespread occurrence of
the key gene Mmda encoding a methylmalonyl decarboxylase
(Reichardt et al., 2014). Also here, the succinate pathway
was identified as the most abundant propionate synthesizing
pathway based on abundance of Mmda. However, the frequent
detection of genes encoding glycerol/diol dehydratases suggests
that 1,2-PD conversion contributes significantly to propionate
formation, and that E. hallii is a relevant species in regard to
intestinal propionate production. Among other species identified
as glycerol and 1,2-PD utilizers by the activity of glycerol/diol
dehydratases and therefore potential propionate producers were
R. obeum and R. gnavus, F. prautii and I. butyriciproducens,
and Veillonella spp. R. gnavus is known to utilize mucins
and degrades fucosylated glycans to propanol and propionate
most likely via the formation of 1,2-PD (Crost et al., 2013).
F. prautii and I. butyriciproducens of Clostridium cluster IV do
not utilize fucose (Kläring et al., 2013). Roseburia inulivorans
which utilizes fucose and degrades it to propionate and
propanol (Scott et al., 2006), was not recovered in the screening
conducted.
Glycerol/diol dehydratases are cobalamin dependent enzymes,
and indeed, E. hallii produces cobalamin. Cobalamin formation
is widespread among gut microbes and a variety of enzymes
are cobalamin co-factor dependent (Degnan et al., 2014b).
Nevertheless, the gut microbiota most likely does not supply
cobalamin to the host in sufficient quantities as the main
site of cobalamin formation is the colon whereas cobalamin
specific receptors are located in the small intestine (Degnan
et al., 2014b). Additionally, microbial competition for cobalamin
is high, an estimated 80% of species requires cobalamin
as co-factor, but only 25% can produce it (Degnan et al.,
2014a). Considering this ecological context, E. hallii again gains
competitive benefit within the gut microbiota as it is able to form
cobalamin.
CONCLUSION
We confirmed E. hallii as a common gut microbe with
versatile substrate utilization spectrum. The ability to utilize
glucose as well the glycan fermentation intermediates acetate,
lactate and 1,2-PD to form butyrate or propionate points at
E. hallii as a key species within the trophic interactions with
the potential to highly impact the metabolic balance with
final impact on gut microbiota/host homeostasis and host
health.
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